News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
French Biotech Company AdipoPharma Secures Funding to Initiate Clinical Trials for its first-in-class compound for Insulin Resistance
Tuesday, November 12, 2024AdipoPharma a biotech company based in France with offices in the US and Belgium announced today it has successfully secured the funding required to commence Phase clinical trials for its promising new Type diabetes treatment The company is set to...
Can-Fite Achieves Milestone with First Patient Dosing in Pancreatic Cancer Phase IIa Clinical Trial
Monday, November 11, 2024CanFite BioPharma Ltd a biotechnology company advancing a pipeline of proprietary small molecule drugs that address oncological and inflammatory diseases today announces the dosing of the first patient in the Phase IIa clinical trial in patients wit...
Cytek® Biosciences Becomes First Company to Add Ability to Detect Subcellular Particles to Its Cell Sorter
Friday, November 08, 2024Cytek Biosciences Inc has introduced an Enhanced Small Particle ESP Detection Option for its Cytek Aurora CS system This is the first commercially available small particle detector on a cell sorter and offers a significant advancement for rapidly evo...
Aptar Pharma Enters into Exclusive Agreement with Cambridge Healthcare Innovations to Commercialize the Quattrii Dry Powder Inhaler Platform
Friday, November 08, 2024Aptar Pharma a global leader in drug delivery and active material science solutions and services today announced that it has entered into an exclusive collaboration agreement with Cambridge Healthcare Innovations CHI to lead the commercialization and...
ARTHEx Biotech Announces FDA Rare Pediatric Designation (RPD) of ATX-01 for the Treatment of Myotonic Dystrophy Type 1 (DM1)
Thursday, November 07, 2024ARTHEx Biotech SL a clinicalstage biotechnology company focused on developing innovative medicines through the modulation of gene expression today announced that the US Food and Drug Administration FDA has granted Rare Pediatric Designation RPD to AT...
BioIVT LLC and KRISHGEN BioSystems Announce Exclusive Commercial Agreement to Enhance Clinical Research in South Asia
Thursday, November 07, 2024BioIVT a global research partner and biospecimen solutions provider for drug and diagnostic development today announced an exclusive agreement with KRISHGEN BioSystems a leading provider of life science research tools and services for over two decade...
Insignis Therapeutics Receives Positive FDA Feedback on IN-001 Clinical Program for Needle-Free Anaphylaxis Treatment
Wednesday, November 06, 2024Insignis Therapeutics a leader in innovative allergy and anaphylaxis treatments announced today that it has received positive feedback from the US Food and Drug Administration FDA with regard to its clinical development program for IN a needle free e...
Dupixent® (dupilumab) Approved in the European Union as the First and Only Medicine for Young Children with Eosinophilic Esophagitis
Wednesday, November 06, 2024Regeneron Pharmaceuticals Inc and Sanofi today announced that the European Commission EC has approved Dupixent dupilumab to treat eosinophilic esophagitis EoE in children as young as year of age Specifically the approval covers children aged to ye...
Ascendis Pharma and Novo Nordisk Sign Collaboration for Development and Commercialization of TransCon Technology-based Products in Metabolic and Cardiovascular Diseases
Tuesday, November 05, 2024Ascendis Pharma AS announced that it has granted Novo Nordisk AS an exclusive worldwide license to the TransCon technology platform to develop manufacture and commercialize Novo Nordisk proprietary products in metabolic diseases including obesity and...
Parse Biosciences Launches Evercode Low Input Fixation for Cells and Nuclei
Tuesday, November 05, 2024Parse Biosciences a leading provider of accessible and scalable single cell sequencing solutions today announced the launch and availability of Evercode Low Input Fixation kits for both cells and nuclei The new kits empower researchers who have a sma...
